Education
About Us
Working with TipRanks
Follow Us
Pfizer (PFE)
NYSE:PFE
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 63.63B | $ 59.55B | $ 100.33B | $ 81.29B | $ 41.65B |
| Gross Profit | $ 41.85B | $ 30.34B | $ 62.09B | $ 46.88B | $ 29.88B |
| Operating Income | $ 16.48B | $ 5.29B | $ 37.55B | $ 20.79B | $ 9.09B |
| EBITDA | $ 18.13B | $ 9.56B | $ 41.03B | $ 30.79B | $ 13.17B |
| Net Income | $ 8.02B | $ 2.13B | $ 31.36B | $ 22.15B | $ 9.16B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 20.48B | $ 12.69B | $ 22.73B | $ 31.07B | $ 12.22B |
| Total Assets | $ 213.40B | $ 226.50B | $ 197.21B | $ 181.48B | $ 154.23B |
| Total Debt | $ 66.99B | $ 70.84B | $ 34.86B | $ 37.00B | $ 38.27B |
| Net Debt | $ 65.95B | $ 67.99B | $ 34.44B | $ 35.05B | $ 36.49B |
| Total Liabilities | $ 124.90B | $ 137.21B | $ 101.29B | $ 104.01B | $ 90.76B |
| Stockholders' Equity | $ 88.20B | $ 89.01B | $ 95.66B | $ 77.20B | $ 63.24B |
| Cash Flow | |||||
| Free Cash Flow | $ 9.84B | $ 4.79B | $ 26.03B | $ 29.87B | $ 11.61B |
| Operating Cash Flow | $ 12.74B | $ 8.70B | $ 29.27B | $ 32.58B | $ 14.40B |
| Investing Cash Flow | $ 2.65B | $ -32.28B | $ -15.78B | $ -22.55B | $ -4.27B |
| Financing Cash Flow | $ -17.14B | $ 26.07B | $ -14.83B | $ -9.82B | $ -9.65B |